STERIS Plc Net Worth
STERIS Plc Net Worth Breakdown | STE |
STERIS Plc Net Worth Analysis
STERIS Plc's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including STERIS Plc's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of STERIS Plc's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform STERIS Plc's net worth analysis. One common approach is to calculate STERIS Plc's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares STERIS Plc's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing STERIS Plc's net worth. This approach calculates the present value of STERIS Plc's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of STERIS Plc's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate STERIS Plc's net worth. This involves comparing STERIS Plc's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into STERIS Plc's net worth relative to its peers.
Enterprise Value |
|
To determine if STERIS Plc is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STERIS Plc's net worth research are outlined below:
| STERIS plc has a strong financial position based on the latest SEC filings | |
| Over 96.0% of the company shares are owned by institutional investors | |
| On 21st of March 2025 STERIS Plc paid $ 0.57 per share dividend to its current shareholders | |
| Latest headline from globenewswire.com: Pharmaceutical Sterility Testing Market Forecast Report to 2030, with Pacific BioLabs, STERIS, Boston Analytical, Nelson Laboratories, Sartorius, SOLVIAS, Rapid Micro Biosystems, Almac Group more |
STERIS Plc uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STERIS plc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STERIS Plc's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
STERIS Plc Target Price Consensus
STERIS target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. STERIS Plc's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Buy |
Most STERIS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand STERIS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of STERIS plc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSTERIS Plc Target Price Projection
STERIS Plc's current and average target prices are 222.02 and 248.26, respectively. The current price of STERIS Plc is the price at which STERIS plc is currently trading. On the other hand, STERIS Plc's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
STERIS Plc Market Quote on 22nd of April 2025
Target Price
Analyst Consensus On STERIS Plc Target Price
Know STERIS Plc's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STERIS Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STERIS plc backward and forwards among themselves. STERIS Plc's institutional investor refers to the entity that pools money to purchase STERIS Plc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Envestnet Asset Management Inc | 2024-12-31 | 466.3 K |
Follow STERIS Plc's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 21.5 B.Market Cap |
|
Project STERIS Plc's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.08 | |
| Return On Capital Employed | 0.09 | 0.14 | |
| Return On Assets | 0.04 | 0.07 | |
| Return On Equity | 0.07 | 0.11 |
When accessing STERIS Plc's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures STERIS Plc's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STERIS Plc's profitability and make more informed investment decisions.
Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.
Evaluate STERIS Plc's management efficiency
STERIS plc has Return on Asset of 0.0559 % which means that on every $100 spent on assets, it made $0.0559 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0961 %, implying that it generated $0.0961 on every 100 dollars invested. STERIS Plc's management efficiency ratios could be used to measure how well STERIS Plc manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.14. At present, STERIS Plc's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.2 B, whereas Intangibles To Total Assets are forecasted to decline to 0.26.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 57.54 | 60.41 | |
| Tangible Book Value Per Share | 1.46 | 2.87 | |
| Enterprise Value Over EBITDA | 20.36 | 17.29 | |
| Price Book Value Ratio | 3.98 | 4.48 | |
| Enterprise Value Multiple | 20.36 | 17.29 | |
| Price Fair Value | 3.98 | 4.48 | |
| Enterprise Value | 6.4 B | 6.7 B |
Understanding the operational decisions made by STERIS Plc management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 4.3828 | Revenue | Quarterly Revenue Growth 0.056 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STERIS Plc insiders, such as employees or executives, is commonly permitted as long as it does not rely on STERIS Plc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STERIS Plc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STERIS Plc Corporate Filings
8K | 3rd of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of February 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 25th of November 2024 Other Reports | ViewVerify |
STERIS Plc Earnings Estimation Breakdown
The calculation of STERIS Plc's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of STERIS Plc is estimated to be 2.264075 with the future projection ranging from a low of 2.19 to a high of 2.285. Please be aware that this consensus of annual earnings estimates for STERIS plc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.19 Lowest | Expected EPS | 2.29 Highest |
STERIS Plc Earnings Projection Consensus
Suppose the current estimates of STERIS Plc's value are higher than the current market price of the STERIS Plc stock. In this case, investors may conclude that STERIS Plc is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and STERIS Plc's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 9 | 95.99% | 2.32 | 2.264075 | 6.22 |
STERIS Plc Earnings History
Earnings estimate consensus by STERIS plc analysts from Wall Street is used by the market to judge STERIS Plc's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only STERIS Plc's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.STERIS Plc Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of STERIS Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
STERIS Plc Earnings per Share Projection vs Actual
Actual Earning per Share of STERIS Plc refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering STERIS plc predict the company's earnings will be in the future. The higher the earnings per share of STERIS Plc, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.STERIS Plc Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as STERIS Plc, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of STERIS Plc should always be considered in relation to other companies to make a more educated investment decision.STERIS Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact STERIS Plc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-05 | 2024-12-31 | 2.3214 | 2.32 | -0.0014 | 0 | ||
2024-11-06 | 2024-09-30 | 2.12 | 2.14 | 0.02 | 0 | ||
2024-08-06 | 2024-06-30 | 1.98 | 2.14 | 0.16 | 8 | ||
2024-05-08 | 2024-03-31 | 2.35 | 2.58 | 0.23 | 9 | ||
2024-02-07 | 2023-12-31 | 2.17 | 2.22 | 0.05 | 2 | ||
2023-11-07 | 2023-09-30 | 2 | 2.03 | 0.03 | 1 | ||
2023-08-01 | 2023-06-30 | 1.87 | 2.0 | 0.13 | 6 | ||
2023-05-10 | 2023-03-31 | 2.15 | 2.3 | 0.15 | 6 | ||
2023-02-08 | 2022-12-31 | 2.19 | 2.02 | -0.17 | 7 | ||
2022-11-09 | 2022-09-30 | 1.98 | 1.99 | 0.01 | 0 | ||
2022-08-02 | 2022-06-30 | 1.92 | 1.9 | -0.02 | 1 | ||
2022-05-12 | 2022-03-31 | 2.02 | 2.04 | 0.02 | 0 | ||
2022-02-08 | 2021-12-31 | 1.96 | 2.12 | 0.16 | 8 | ||
2021-11-02 | 2021-09-30 | 1.82 | 1.99 | 0.17 | 9 | ||
2021-08-09 | 2021-06-30 | 1.49 | 1.76 | 0.27 | 18 | ||
2021-05-18 | 2021-03-31 | 1.78 | 1.63 | -0.15 | 8 | ||
2021-02-02 | 2020-12-31 | 1.52 | 1.73 | 0.21 | 13 | ||
2020-11-02 | 2020-09-30 | 1.27 | 1.48 | 0.21 | 16 | ||
2020-08-03 | 2020-06-30 | 0.96 | 1.31 | 0.35 | 36 | ||
2020-05-13 | 2020-03-31 | 1.58 | 1.64 | 0.06 | 3 | ||
2020-02-10 | 2019-12-31 | 1.42 | 1.45 | 0.03 | 2 | ||
2019-11-04 | 2019-09-30 | 1.25 | 1.32 | 0.07 | 5 | ||
2019-08-05 | 2019-06-30 | 1.11 | 1.23 | 0.12 | 10 | ||
2019-05-13 | 2019-03-31 | 1.43 | 1.53 | 0.1 | 6 | ||
2019-02-11 | 2018-12-31 | 1.25 | 1.26 | 0.01 | 0 | ||
2018-11-06 | 2018-09-30 | 1.09 | 1.1 | 0.01 | 0 | ||
2018-08-08 | 2018-06-30 | 0.99 | 1.0 | 0.01 | 1 | ||
2018-05-09 | 2018-03-31 | 1.22 | 1.24 | 0.02 | 1 | ||
2018-02-07 | 2017-12-31 | 1.07 | 1.12 | 0.05 | 4 | ||
2017-11-01 | 2017-09-30 | 0.94 | 0.94 | 0.0 | 0 | ||
2017-08-08 | 2017-06-30 | 0.8 | 0.85 | 0.05 | 6 | ||
2017-05-09 | 2017-03-31 | 1.06 | 1.11 | 0.05 | 4 | ||
2017-02-07 | 2016-12-31 | 1.03 | 0.98 | -0.05 | 4 | ||
2016-11-02 | 2016-09-30 | 0.9 | 0.89 | -0.01 | 1 | ||
2016-08-09 | 2016-06-30 | 0.77 | 0.79 | 0.02 | 2 | ||
2016-05-18 | 2016-03-31 | 1.04 | 0.9 | -0.14 | 13 | ||
2016-02-09 | 2015-12-31 | 0.94 | 0.98 | 0.04 | 4 | ||
2015-10-30 | 2015-09-30 | 0.76 | 0.83 | 0.07 | 9 | ||
2015-08-04 | 2015-06-30 | 0.61 | 0.62 | 0.01 | 1 | ||
2015-05-07 | 2015-03-31 | 0.89 | 0.98 | 0.09 | 10 | ||
2015-02-04 | 2014-12-31 | 0.73 | 0.79 | 0.06 | 8 | ||
2014-11-04 | 2014-09-30 | 0.63 | 0.68 | 0.05 | 7 | ||
2014-08-05 | 2014-06-30 | 0.54 | 0.54 | 0.0 | 0 | ||
2014-05-08 | 2014-03-31 | 0.86 | 0.91 | 0.05 | 5 | ||
2014-02-05 | 2013-12-31 | 0.69 | 0.59 | -0.1 | 14 | ||
2013-10-30 | 2013-09-30 | 0.54 | 0.55 | 0.01 | 1 | ||
2013-08-07 | 2013-06-30 | 0.56 | 0.44 | -0.12 | 21 | ||
2013-05-07 | 2013-03-31 | 0.65 | 0.64 | -0.01 | 1 | ||
2013-02-06 | 2012-12-31 | 0.56 | 0.53 | -0.03 | 5 | ||
2012-10-31 | 2012-09-30 | 0.52 | 0.46 | -0.06 | 11 | ||
2012-08-02 | 2012-06-30 | 0.45 | 0.53 | 0.08 | 17 | ||
2012-05-08 | 2012-03-31 | 0.59 | 0.59 | 0.0 | 0 | ||
2012-02-07 | 2011-12-31 | 0.61 | 0.59 | -0.02 | 3 | ||
2011-11-02 | 2011-09-30 | 0.55 | 0.5 | -0.05 | 9 | ||
2011-08-02 | 2011-06-30 | 0.47 | 0.48 | 0.01 | 2 | ||
2011-05-09 | 2011-03-31 | 0.62 | 0.61 | -0.01 | 1 | ||
2011-02-08 | 2010-12-31 | 0.58 | 0.57 | -0.01 | 1 | ||
2010-11-03 | 2010-09-30 | 0.54 | 0.55 | 0.01 | 1 | ||
2010-08-03 | 2010-06-30 | 0.45 | 0.46 | 0.01 | 2 | ||
2010-05-06 | 2010-03-31 | 0.53 | 0.55 | 0.02 | 3 | ||
2010-02-02 | 2009-12-31 | 0.48 | 0.69 | 0.21 | 43 | ||
2009-11-03 | 2009-09-30 | 0.44 | 0.54 | 0.1 | 22 | ||
2009-07-30 | 2009-06-30 | 0.4 | 0.43 | 0.03 | 7 | ||
2009-05-07 | 2009-03-31 | 0.4 | 0.47 | 0.07 | 17 | ||
2009-01-27 | 2008-12-31 | 0.35 | 0.53 | 0.18 | 51 | ||
2008-10-30 | 2008-09-30 | 0.31 | 0.46 | 0.15 | 48 | ||
2008-07-30 | 2008-06-30 | 0.25 | 0.43 | 0.18 | 72 | ||
2008-05-07 | 2008-03-31 | 0.5 | 0.59 | 0.09 | 18 | ||
2008-01-30 | 2007-12-31 | 0.4 | 0.34 | -0.06 | 15 | ||
2007-10-30 | 2007-09-30 | 0.26 | 0.25 | -0.01 | 3 | ||
2007-07-25 | 2007-06-30 | 0.22 | 0.21 | -0.01 | 4 | ||
2007-05-08 | 2007-03-31 | 0.35 | 0.45 | 0.1 | 28 | ||
2007-01-31 | 2006-12-31 | 0.32 | 0.32 | 0.0 | 0 | ||
2006-11-07 | 2006-09-30 | 0.22 | 0.25 | 0.03 | 13 | ||
2006-08-02 | 2006-06-30 | 0.21 | 0.22 | 0.01 | 4 | ||
2006-05-10 | 2006-03-31 | 0.41 | 0.34 | -0.07 | 17 | ||
2006-01-31 | 2005-12-31 | 0.34 | 0.34 | 0.0 | 0 | ||
2005-11-09 | 2005-09-30 | 0.21 | 0.24 | 0.03 | 14 | ||
2005-08-09 | 2005-06-30 | 0.25 | 0.25 | 0.0 | 0 | ||
2005-05-17 | 2005-03-31 | 0.42 | 0.36 | -0.06 | 14 | ||
2005-01-26 | 2004-12-31 | 0.32 | 0.35 | 0.03 | 9 | ||
2004-10-27 | 2004-09-30 | 0.28 | 0.27 | -0.01 | 3 | ||
2004-07-27 | 2004-06-30 | 0.25 | 0.25 | 0.0 | 0 | ||
2004-04-23 | 2004-03-31 | 0.43 | 0.43 | 0.0 | 0 | ||
2004-01-22 | 2003-12-31 | 0.35 | 0.38 | 0.03 | 8 | ||
2003-10-23 | 2003-09-30 | 0.29 | 0.29 | 0.0 | 0 | ||
2003-07-24 | 2003-06-30 | 0.21 | 0.23 | 0.02 | 9 | ||
2003-04-24 | 2003-03-31 | 0.37 | 0.38 | 0.01 | 2 | ||
2003-01-23 | 2002-12-31 | 0.28 | 0.3 | 0.02 | 7 | ||
2002-10-24 | 2002-09-30 | 0.24 | 0.26 | 0.02 | 8 | ||
2002-07-23 | 2002-06-30 | 0.14 | 0.18 | 0.04 | 28 | ||
2002-04-25 | 2002-03-31 | 0.23 | 0.26 | 0.03 | 13 | ||
2002-01-24 | 2001-12-31 | 0.2 | 0.2 | 0.0 | 0 | ||
2001-10-18 | 2001-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2001-07-19 | 2001-06-30 | 0.05 | 0.08 | 0.03 | 60 | ||
2001-04-26 | 2001-03-31 | 0.16 | 0.17 | 0.01 | 6 | ||
2001-01-25 | 2000-12-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2000-10-19 | 2000-09-30 | 0.25 | 0.1 | -0.15 | 60 | ||
2000-07-26 | 2000-06-30 | -0.01 | 0.01 | 0.02 | 200 | ||
2000-04-26 | 2000-03-31 | 0.12 | 0.01 | -0.11 | 91 | ||
2000-01-26 | 1999-12-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1999-10-27 | 1999-09-30 | 0.21 | 0.22 | 0.01 | 4 | ||
1999-07-29 | 1999-06-30 | 0.23 | 0.14 | -0.09 | 39 | ||
1999-04-28 | 1999-03-31 | 0.36 | 0.42 | 0.06 | 16 | ||
1999-01-26 | 1998-12-31 | 0.31 | 0.33 | 0.02 | 6 | ||
1998-10-27 | 1998-09-30 | 0.27 | 0.27 | 0.0 | 0 | ||
1998-07-28 | 1998-06-30 | 0.2 | 0.21 | 0.01 | 5 | ||
1998-04-29 | 1998-03-31 | 0.28 | 0.29 | 0.01 | 3 | ||
1998-01-28 | 1997-12-31 | 0.25 | 0.26 | 0.01 | 4 | ||
1997-10-27 | 1997-09-30 | 0.22 | 0.22 | 0.0 | 0 | ||
1997-07-23 | 1997-06-30 | 0.16 | 0.17 | 0.01 | 6 | ||
1997-04-30 | 1997-03-31 | 0.2 | 0.23 | 0.03 | 15 | ||
1997-01-30 | 1996-12-31 | 0.19 | 0.19 | 0.0 | 0 | ||
1996-10-30 | 1996-09-30 | 0.15 | 0.17 | 0.02 | 13 | ||
1996-07-29 | 1996-06-30 | 0.14 | 0.14 | 0.0 | 0 | ||
1996-04-23 | 1996-03-31 | 0.1 | 0.1 | 0.0 | 0 | ||
1996-01-25 | 1995-12-31 | 0.09 | 0.09 | 0.0 | 0 |
STERIS Plc Corporate Directors
| Richard Breeden | Independent Director | Profile | |
| Michael Wood | Independent Director | Profile | |
| Paul Martin | Independent Director | Profile | |
| Jacqueline Kosecoff | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.238 | Dividend Share 2.18 | Earnings Share 6.22 | Revenue Per Share | Quarterly Revenue Growth 0.056 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.